Contact Person : Rachel Zablow Katzir; Last Date for the submission of abstract : 41649; Description : AD/PD will build on its well-earned reputation for unravelling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases.